170 related articles for article (PubMed ID: 20037446)
61. S-1 and gemcitabine as an outpatient-based regimen in patients with advanced or metastatic pancreatic cancer.
Kim MK; Lee KH; Jang BI; Kim TN; Eun JR; Bae SH; Ryoo HM; Lee SA; Hyun MS
Jpn J Clin Oncol; 2009 Jan; 39(1):49-53. PubMed ID: 19060295
[TBL] [Abstract][Full Text] [Related]
62. [A case of Complete Response(CR)to combination therapy of S-1 and Gemcitabine(GEM)for unresectable pancreatic cancer].
Miyagawa K; Yata Y; Yamaoka N; Sagara Y
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1145-7. PubMed ID: 20567125
[TBL] [Abstract][Full Text] [Related]
63. TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial).
Ioka T; Ueno M; Ueno H; Park JO; Chang HM; Sasahira N; Kanai M; Chung IJ; Ikeda M; Nakamori S; Mizuno N; Omuro Y; Yamaguchi T; Hara H; Sugimori K; Furuse J; Maguchi H; Furukawa M; Fukuzawa K; Kim JS; Yukisawa S; Takeuchi M; Okusaka T; Boku N; Hyodo I
Eur J Cancer; 2019 Jan; 106():78-88. PubMed ID: 30471651
[TBL] [Abstract][Full Text] [Related]
64. [A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy].
Ohmura Y; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Monden M; Mori M; Doki Y
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2428-9. PubMed ID: 20037445
[TBL] [Abstract][Full Text] [Related]
65. [Non-surgical treatment for pancreatic cancer].
Okusaka T; Ueno H; Ikeda M; Morizane C
Nihon Shokakibyo Gakkai Zasshi; 2006 Apr; 103(4):391-7. PubMed ID: 16629457
[No Abstract] [Full Text] [Related]
66. Clinical implication of peritoneal cytology in the pancreatic cancer patients who underwent curative resection followed by adjuvant gemcitabine or S-1 chemotherapy.
Aoyama T; Katayama Y; Murakawa M; Shiozawa M; Morimoto M; Yamamoto N; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Hepatogastroenterology; 2015; 62(137):200-6. PubMed ID: 25911897
[TBL] [Abstract][Full Text] [Related]
67. [Two Cases of Liver Metastasis from Pancreatic Cancer with a Complete Response Owing to Chemotherapy].
Suda H; Omori K; Suematsu Y; Hiratsuka M; Takahashi M; Saito H; Ishibashi Y; Morita A; Wakabayashi K; Ito Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2388-90. PubMed ID: 26805373
[TBL] [Abstract][Full Text] [Related]
68. Successful neoadjuvant treatment with radiochemotherapy and systemic chemotherapy for the locally advanced pancreatic head cancer: report of a case.
Masui T; Doi R; Ogawa K; Kami K; Machimoto T; Seo S; Kawaguchi Y; Egawa H; Matsugu Y; Uemoto S
Hepatogastroenterology; 2011; 58(110-111):1809-13. PubMed ID: 22086705
[TBL] [Abstract][Full Text] [Related]
69. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
Li Y; Sun J; Jiang Z; Zhang L; Liu G
J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
[TBL] [Abstract][Full Text] [Related]
70. A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer.
Shinchi H; Maemura K; Mataki Y; Kurahara H; Sakoda M; Ueno S; Hiraki Y; Nakajo M; Natsugoe S; Takao S
J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):152-8. PubMed ID: 21647560
[TBL] [Abstract][Full Text] [Related]
71. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
72. [Gemcitabine plus S-1 combination therapy (GS therapy) for pancreatic cancer patients with high-grade hepatic metastasis].
Matsumoto T; Takeji S; Asagi A; Kajiwara T; Nishina T; Hori S; Ikeda Y; Nadano S; Iguchi H
Nihon Shokakibyo Gakkai Zasshi; 2011 Dec; 108(12):2003-9. PubMed ID: 22139487
[TBL] [Abstract][Full Text] [Related]
73. [A Case of Pancreatic Head Cancer Showing Pathological Complete Response to Neoadjuvant Chemoradiation Therapy].
Nakama Y; Kawahara R; Nomura Y; Muroya D; Arai S; Ishikawa H; Yasunaga M; Horiuchi H; Akagi Y; Tanaka H; Yasumoto M; Okabe Y; Torimura T; Naito Y; Okuda K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2376-8. PubMed ID: 26805369
[TBL] [Abstract][Full Text] [Related]
74. [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine as second-line chemotherapy].
Kawamoto K; Yamaguchi K; Okabe M; Tsuruta A; Morimoto Y; Niwano M; Sano K; Paku T; Imai S; Yoshida Y; Ito T; Ogasahara K
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1131-4. PubMed ID: 17637556
[TBL] [Abstract][Full Text] [Related]
75. Nutritional impact of active hexose-correlated compound for patients with resectable or borderline-resectable pancreatic cancer treated with neoadjuvant therapy.
Hashimoto D; Satoi S; Yamamoto T; Yamaki S; Ishida M; Ryota H; Sakaguchi T; Hirooka S; Inoue K; Sekimoto M
Surg Today; 2021 Nov; 51(11):1872-1876. PubMed ID: 34086127
[TBL] [Abstract][Full Text] [Related]
76. [Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy].
Takita M; Iwasaki E; Hatogai K; Kishino R; Seki E; Izumiya M; Maeda N; Nakazawa A; Mizuki A; Handa K; Shimoyama Y; Mukai K; Higuchi H; Takaishi H; Hibi T; Tsukada N
Nihon Shokakibyo Gakkai Zasshi; 2011 Jul; 108(7):1263-70. PubMed ID: 21737979
[TBL] [Abstract][Full Text] [Related]
77. [A Case of Successful Stomach-Preserving Pancreaticoduodenectomy with Celiac Artery Resection after Neoadjuvant Chemoradiation Therapy for Pancreatic Cancer with Hepatic Arterial Variation].
Kyakumoto Y; Mizuma M; Abe T; Takadate T; Fukase K; Otsuka H; Sakata N; Nakagawa K; Morikawa T; Hayashi H; Naitoh T; Motoi F; Kanno A; Shimosegawa T; Unno M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1966-1968. PubMed ID: 28133191
[TBL] [Abstract][Full Text] [Related]
78. Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.
Badiyan SN; Olsen JR; Lee AY; Yano M; Menias CO; Khwaja S; Wang-Gillam A; Strasberg SM; Hawkins WG; Linehan DC; Myerson RJ; Parikh PJ
Am J Clin Oncol; 2016 Feb; 39(1):1-7. PubMed ID: 26132367
[TBL] [Abstract][Full Text] [Related]
79. Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?
Kim R; Saif MW
JOP; 2007 May; 8(3):279-88. PubMed ID: 17495356
[TBL] [Abstract][Full Text] [Related]
80. Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakagawa N; Takahashi S; Sueda T
Cancer Chemother Pharmacol; 2017 Jan; 79(1):37-47. PubMed ID: 27878355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
